GANX insider filings
Gain Therapeutics, Inc. — 49 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-07-17. Screen GANX transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 6 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| GOLDSTEIN DOV A MD — Director | 1 | — | — | 1 |
| HASLER HANS PETER — Director | 1 | — | — | 1 |
| Islam Khalid — Director | 1 | — | — | 1 |
| Melincoff Gwen A — Director | 1 | — | — | 1 |
| Nicaise Claude — Director | 1 | — | — | 1 |
| Riley Jeffrey Scott — Director | 1 | — | — | 1 |
Recent insider filings — Gain Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | Islam Khalid — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Nicaise Claude — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Melincoff Gwen A — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Riley Jeffrey Scott — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | HASLER HANS PETER — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | GOLDSTEIN DOV A MD — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | Fuggetta Gianluca — See Remark | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | Mack Gene — CEO, President, Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Islam Khalid — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Nicaise Claude — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Melincoff Gwen A — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Riley Jeffrey Scott — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | RICHMAN ERIC I — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | HASLER HANS PETER — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | GOLDSTEIN DOV A MD — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Fuggetta Gianluca — See Remark | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Mack Gene — CEO, President, Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Mack Gene — CEO, President, Director | Grant/award (A): 271,325 (derivative) @ $0 | EDGAR |
| 2024-08-12 | 4 | Mack Gene — CFO and Interim CEO | Purchase (P): 14,400 @ $1.01 | EDGAR |
| 2024-08-12 | 4 | Islam Khalid — Executive Chairman, Director | Purchase (P): 50,000 @ $1.00 | EDGAR |
| 2024-07-01 | 4 | RICHMAN ERIC I — Director | Purchase (P): 5,000 @ $1.23 · Purchase (P): 12,000 @ $1.21 | EDGAR |
| 2024-06-26 | 4 | Islam Khalid — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | Nicaise Claude — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | Melincoff Gwen A — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | Riley Jeffrey Scott — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | RICHMAN ERIC I — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | HASLER HANS PETER — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | GOLDSTEIN DOV A MD — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-04-08 | 4 | Mack Gene — Chief Financial Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-04-01 | 4 | Riley Jeffrey Scott — Director | Purchase (P): 30,000 @ $3.86 | EDGAR |
| 2024-03-28 | 4 | Alder Matthias — Chief Executive Officer, Director | Option exercise (M): 18,750 · Option exercise (M): 825 · Option exercise (M): 637 · Tax withholding (F): 6,085 @ $4.06 · Option exercise (M): 18,750 (derivative) @ $0 · Option exercise (M): 825 (derivative) @ $0 · +1 more | EDGAR |
| 2024-03-25 | 4 | Fuggetta Gianluca — See Remark | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-03-25 | 4 | Alder Matthias — Chief Executive Officer, Director | Grant/award (A): 370,000 (derivative) @ $0 | EDGAR |
| 2023-12-22 | 4 | Alder Matthias — Chief Executive Officer, Director | Option exercise (M): 637 · Sale (S): 206 @ $2.46 · Option exercise (M): 637 (derivative) @ $0 | EDGAR |
| 2023-12-14 | 4 | Alder Matthias — Chief Executive Officer, Director | Sale (S): 1,820 @ $2.50 | EDGAR |
| 2023-10-03 | 4 | Alder Matthias — Chief Executive Officer, Director | Option exercise (M): 825 · Option exercise (M): 825 (derivative) @ $0 | EDGAR |
| 2023-09-22 | 4 | Alder Matthias — Chief Executive Officer, Director | Option exercise (M): 2,550 · Option exercise (M): 2,550 (derivative) @ $0 | EDGAR |
| 2023-09-22 | 4 | RICHMAN ERIC I — Director | Option exercise (M): 54,900 · Option exercise (M): 54,900 (derivative) @ $0 | EDGAR |
| 2023-07-05 | 4 | Alder Matthias — Chief Executive Officer, Director | Option exercise (M): 3,300 · Option exercise (M): 3,300 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | Islam Khalid — Director | Grant/award (A): 10,500 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | Nicaise Claude — Director | Grant/award (A): 10,500 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | Melincoff Gwen A — Director | Grant/award (A): 10,500 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | Riley Jeffrey Scott — Director | Grant/award (A): 10,500 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | HASLER HANS PETER — Director | Grant/award (A): 10,500 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | GOLDSTEIN DOV A MD — Director | Grant/award (A): 10,500 (derivative) @ $0 | EDGAR |
| 2023-04-12 | 4 | Ballantyne Charles Evan — Chief Financial Officer | Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-03-27 | 4 | Calabrese Salvatore — Chief Financial Officer | Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-03-27 | 4 | Fuggetta Gianluca — Principal Accounting Officer | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-03-27 | 4 | Alder Matthias — Chief Executive Officer, Director | Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Gain Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-01 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-09-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-29 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-25 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-26 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-18 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GANX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →